Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)
Clinical trial NCT05155839 · UNKNOWN
Trial details
- NCT number
- NCT05155839
- Sponsor
- Shanghai Miracogen Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2022-10-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.